Phase 1/2 Trial of Tinostamustine to Treat Blood Cancers Opens 2nd Stage
News
The expansion stage of a Phase 1/2 trial testing tinostamustine in relapsed or refractory types of lymphoma and other blood cancers has enrolled a first patient. The study (NCT02576496) is currently ... Read more